Cairo university
Cairo, Egypt
NCT Number: NCT03737682
Assessment of pulp inflammation by hemostasis achievement after pulp exposure
Looking for future studies?
Notify Me5 year–7 year
All sexes
Observational
Cairo, Egypt
The possibility has been raised of diagnosing pulpal pathological status using the cytokines that are released during the inflammation process in healthy as well as infected tooth pulp. Cytokines are small polypeptides secreted by leucocytes and other inflammatory cells and are known to play important roles in the intensity and duration of the immune response
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels
Time frame: After 5 minutes
to measure cytokines levels after coronal pulpal removal
Time frame: After 5 minutes
to measure cytokines levels after coronal pulpal removal
Time frame: 3,6,9,12 months
To assess postoperative pain by verbal questioning and To observe presence or absence of radiolucency and root resorption or pathological condition
Looking for future studies?
Notify MeCairo University
Other
Hemostasis Achievement Reflecting Inflammatory Status of the Pulp Based on Cytokine Levels: A Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07773844
First Aid, Hemorrhage
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07764055
Hemorrhage, Oxidized Regenerated Cellulose
Guangzhou, China
View Trial DetailsNCT05573841
Acute Coagulopathy, Hemorrhage
Stockholm, Sweden
View Trial DetailsNCT04186416
Fluid Responsiveness, Hemorrhage
Paris, France
View Trial Details